Pfizer and BioNTech to submit emergency use authorization request to FDA for COVID-19 vaccine
Pfizer and BioNTech announced on Friday that they will be submitting an emergency use authorization request to the US Food and Drug Administration (FDA) on Friday.
Additional details of the announcement revealed that companies will be ready to distribute the vaccine within hours after the authorization.
"To date, Data Monitoring Committee (DMC) for the study has not reported any serious safety concerns related to the vaccine," Pfizer and BioNTech reiterated.
Market reaction
The S&P 500 Futures erased daily losses and turned flat at 3,578 ahead of the opening bell.
Reprinted from FXStreet. The copyright is reserved by the original author.
Reprinted from FXStreet，the copyright all reserved by the original author.
Edited 23 Nov 2020, 11:03
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.